Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

LLY

Lilly(Eli) & Co

Sep 18 • 04:00PM ET

904.97

Dollar change -1.21
Percentage change -0.13	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VOO SPY VUG IVV XLV IWF VHT QUAL IVW

Scroll to Statements

Index	S&P 500	P/E	113.04	EPS (ttm)	8.01	Insider Own	10.38%	Shs Outstand	949.38M	Perf Week	-1.73%
Market Cap	860.11B	Forward P/E	40.24	EPS next Y	22.49	Insider Trans	-2.00%	Shs Float	851.67M	Perf Month	-1.83%
Income	7.34B	PEG	1.55	EPS next Q	4.49	Inst Own	72.98%	Short Float	0.74%	Perf Quarter	1.52%
Sales	38.92B	P/S	22.10	EPS this Y	157.17%	Inst Trans	0.66%	Short Ratio	1.97	Perf Half Y	17.11%
Book/sh	14.26	P/B	63.44	EPS next Y	38.38%	ROA	11.59%	Short Interest	6.27M	Perf Year	58.41%
Cash/sh	3.54	P/C	255.68	EPS next 5Y	72.95%	ROE	59.63%	52W Range	516.57 - 972.53	Perf YTD	55.25%
Dividend Est.	5.62 (0.62%)	P/FCF	3336.35	EPS past 5Y	13.74%	ROI	19.69%	52W High	-6.95%	Beta	0.43
Dividend TTM	5.03 (0.56%)	Quick Ratio	0.87	Sales past 5Y	9.91%	Gross Margin	80.75%	52W Low	75.19%	ATR (14)	23.06
Dividend Ex-Date	Aug 15, 2024	Current Ratio	1.11	EPS Y/Y TTM	12.98%	Oper. Margin	34.50%	RSI (14)	46.74	Volatility	1.81% 2.27%
Employees	43000	Debt/Eq	2.13	Sales Y/Y TTM	31.87%	Profit Margin	18.86%	Recom	1.56	Target Price	1011.67
Option/Short	Yes / Yes	LT Debt/Eq	1.75	EPS Q/Q	68.00%	Payout	77.91%	Rel Volume	0.56	Prev Close	906.18
Sales Surprise	13.24%	EPS Surprise	42.93%	Sales Q/Q	35.98%	Earnings	Aug 08 BMO	Avg Volume	3.19M	Price	904.97
SMA20	-3.21%	SMA50	0.99%	SMA200	16.48%	Trades		Volume	1,773,602	Change	-0.13%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$360 → $375
Mar-06-23	Initiated	Jefferies	Hold	$290
Feb-15-23	Downgrade	Societe Generale	Hold → Sell
Nov-18-22	Initiated	Credit Suisse	Outperform	$395
Sep-22-22	Upgrade	UBS	Neutral → Buy	$335 → $363
May-23-22	Initiated	SVB Leerink	Outperform	$341
Apr-06-22	Resumed	Morgan Stanley	Overweight	$265 → $364
Mar-10-22	Initiated	Daiwa Securities	Outperform	$286

Show Previous Ratings

Sep-18-24 05:49PM	Why ResMed Stock Tumbled by 5% Today (Motley Fool)
05:33PM	Eli Lilly and Company (LLY): Hedge Funds Are Bullish On This Counter Cyclical and Defensive Stock to Invest In (Insider Monkey)
05:15PM	S&P 500 Gains and Losses Today: ResMed Drops as Weight-Loss Drugs Threaten Demand (Investopedia)
11:28AM	Weight loss drug pricing under fire with pills on the horizon (Yahoo Finance Video)
10:07AM	This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk's and Eli Lilly's Weight Loss Treatments (Motley Fool)
07:11PM	Loading…
Sep-17-24 07:11PM	Jim Cramer Shows Confidence In The Eli Lilly and Company (LLY)'s Future Growth (Insider Monkey)
05:31PM	Weight-loss drug competition heats up with growing pill market (Yahoo Finance)
10:53AM	FDA releases draft guidance on oncology multiregional clinical trials (Clinical Trials Arena)
10:15AM	Prediction: This Will Be the First Healthcare Stock to Join the Trillion-Dollar Club (Motley Fool)
09:00AM	Is Most-Watched Stock Eli Lilly and Company (LLY) Worth Betting on Now? (Zacks)
07:00AM	1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc) (Motley Fool)
06:12AM	ESMO 2024: Eli Lilly brings the competition to Novartis with new results in mCRPC (Clinical Trials Arena)
Sep-16-24 08:50PM	Eli Lilly and Company (LLY): Among Morgan Stanleys Best Stock Picks for 2025 (Insider Monkey)
01:36PM	Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss (Benzinga)
06:00AM	This 'forgotten child' is one of the best biotech plays: Analyst (Yahoo Finance Video)
03:12AM	Loading…
03:12AM	Lillys EBGLYSS gains FDA approval for patients aged 12 and older (Pharmaceutical Technology)
Sep-15-24 03:00AM	Worlds Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna (Barrons.com)
Sep-14-24 01:55PM	Is Eli Lilly and Company (LLY) an Unstoppable Dividend Stocks to Buy? (Insider Monkey)
07:30AM	3 Stocks to Buy and Hold Forever (Motley Fool)
Sep-13-24 10:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
04:07PM	FDA Approves Lilly's EBGLYSS (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis (PR Newswire)
01:17PM	Calls of the Day: Vistra, Garmin, Tesla and Eli Lilly (CNBC TV)
11:13AM	Eli Lilly Investing $1.8B to Expand its Manufacturing Facilities (Design & Development Today)
08:45AM	6 Incredible Reasons to Invest in Eli Lilly (Motley Fool)
06:55AM	Subcutaneous Tecentriq gets FDA OK; Gilead shot succeeds in second HIV trial (BioPharma Dive)
04:12AM	Eli Lilly to invest $1.8bn in manufacturing capacity in Ireland (Pharmaceutical Technology)
Sep-12-24 04:33PM	Eli Lilly Invests $1.8B To Expand Drug Output in Ireland (Investopedia)
01:17PM	Is Eli Lilly Stock A Buy After Slashing The Price Of Its New Weight-Loss Drug? (Investor's Business Daily)
11:53AM	EASD 2024: Innovent shows off mazdutides efficacy in diabetes and obesity (Pharmaceutical Technology)
10:28AM	Roche Setback Is Big for Eli Lilly, Novo Nordisk Stock as Obesity Drug Battle Ramps Up (Barrons.com)
09:24AM	Loading…
09:24AM	Eli Lilly doubles down on Irish operations with $1.8 bln Investment (Investing.com)
06:00AM	Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now (Motley Fool)
05:30AM	Lilly expands manufacturing footprint in Ireland with $1.8 billion investment (PR Newswire)
04:30AM	Bull of the Day: Eli Lilly (LLY) (Zacks)
03:19AM	Roche Shares Drop on Concern About Obesity Pill Side Effects (Bloomberg)
Sep-11-24 04:38PM	Novo Jumps After Weight-Loss Pill Tops Wegovy; Lilly, Viking Shares Rise (Investor's Business Daily)
04:30PM	Why Analysts Predict a November Surge for Viking Therapeutics Stock (Investopedia)
03:45PM	Novo Nordisks new weight-loss pill Amycretin beats Wegovy in early trial (FastCompany)
10:38AM	Obesity Drug Safe for Kids, Study Finds. Novo Nordisk Stock Rises. (Barrons.com)
09:18AM	Novo Nordisk Jumps After New Weight-Loss Pill Tops Wegovy; Eli Lilly, Viking Shares Rise (Investor's Business Daily)
08:20AM	Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound) (Motley Fool)
08:08AM	Novo Nordisk Stock Rises After Study Finds Obesity Drug Safe For Kids (Barrons.com)
06:45AM	Prediction: These 2 Companies Will Split Their Stocks by 2027 (Motley Fool)
06:00AM	GSK discontinues herpes vaccine; Roivant launches new vant around hypertension drug (BioPharma Dive)
Sep-10-24 03:54PM	EASD 2024: Eli Lilly releases Phase III data for once-weekly insulin in diabetes (Pharmaceutical Technology)
12:33PM	EASD 2024: Mazdutide improves cardiometabolic function in overweight patients (Clinical Trials Arena)
11:57AM	With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes (PR Newswire)
11:53AM	EASD 2024: Cardiovascular and inflammatory markers reduce after orforglipron treatment (Clinical Trials Arena)
11:18AM	Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes (PR Newswire)
10:28AM	Analyst Report: Eli Lilly and Company (Morningstar Research)
06:49AM	Eli Lillys new CFO is a 23-year company veteranshowing how pharma firms rely on a deep bench of qualified talent (Fortune)
Sep-09-24 04:03PM	Sorry, Apple And Nvidia. Funds Are Streaming Into This Non-Mag 7 Stock Now. (Investor's Business Daily)
03:24PM	Lilly appoints insider as finance chief amid rising investments to boost capacity (Reuters)
01:28PM	Calls of the Day: Eli Lilly and Netflix (CNBC TV)
12:35PM	Is Eli Lilly and Company (LLY) a Good Big Company Stock to Buy Now? (Insider Monkey)
12:26PM	Eli Lilly Names Lucas Montarce Chief Financial Officer (The Wall Street Journal)
09:58AM	Terns Pharmaceuticals Stock Is Soaring on Good Data for Weight-Loss Pill (Barrons.com)
06:45AM	Lilly appoints Lucas Montarce as executive vice president and chief financial officer (PR Newswire)
Sep-08-24 06:45AM	This Unstoppable Stock Has Gained 100,203% Over The Last 50 Years, Creating Many Millionaires in the Process. Here Are 3 Reasons I Think It Will Continue to Create Generational Wealth. (Motley Fool)
05:42AM	Beyond Mounjaro and Zepbound: 6 Other Drugs That Could Be Blockbusters for Eli Lilly (Motley Fool)
03:22AM	Eli Lilly And Company (LLY): Are Hedge Funds Bullish On This ESG Stock? (Insider Monkey)
02:30AM	Jim Cramer Says Eli Lilly and Company (LLY) Has the Biggest Pharmaceutical Potential (Insider Monkey)
01:52AM	Eli Lilly and Company (LLY): Do Hedge Funds Recommend This Biotech Stock? (Insider Monkey)
Sep-07-24 06:57PM	Does Eli Lilly and Company (LLY)s Financial Performance Make It A Safe Stock To Invest In Now? (Insider Monkey)
Sep-06-24 04:52PM	Why Big Pharma is betting on telehealth strategies (Yahoo Finance)
03:38PM	Sorry, Apple And Nvidia. Top Funds Love This Non-Mag 7 Stock Now. (Investor's Business Daily)
02:03PM	Top Funds Love This Non-Mag 7 Stock As Nvidia, Apple Remain AWOL (Investor's Business Daily)
02:03PM	Nvidia And Apple Get The (Fading) Glory. This Snubbed Stock Collects The Cash. (Investor's Business Daily)
01:31PM	Four Biotech Stocks Rally Toward Buy Points As Funds Load Up (Investor's Business Daily)
11:25AM	Stock Of The Day: Here's Why Weight-Loss Drug Maker Eli Lilly Has Reversed (Benzinga)
10:56AM	The Attraction to Stable Dividend Growth (FX Empire)
10:46AM	Who Can Use the New Obesity Drugs? Nearly Half of Adults Under 65 Are Eligible. (Barrons.com)
09:00AM	Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:00AM	Nvidia May Get The Glory. But This Snubbed Stock Gets The Money. (Investor's Business Daily)
04:35AM	This Big Move by Eli Lilly May Solve the Weight Loss Drug Market's Biggest Problem (Motley Fool)
04:12AM	Lillys efsitora shows promise in Phase III type 2 diabetes trials (Clinical Trials Arena)
Sep-05-24 11:53AM	Lilly partners with Haya for lncRNA obesity target deal worth $1bn (Pharmaceutical Technology)
11:32AM	Novo Nordisks Ozempic Shortage Is Worsening. Thats Good for Eli Lilly Stock. (Barrons.com)
10:23AM	Eli Lilly Makes Strides on Weekly Insulin Shot as Novo Nordisk Stumbles (Barrons.com)
09:47AM	Eli Lilly's Once-Weekly Insulin Shows Non-Inferior Blood Sugar Reduction Vs Frequently Used Daily Insulins In Long Term Trials (Benzinga)
09:33AM	Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs (Reuters)
09:13AM	Qiagen and Lilly team up for Alzheimers genotype test (Medical Device Network)
08:15AM	Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know. (Motley Fool)
07:57AM	Lilly builds case for weekly insulin shot (BioPharma Dive)
06:45AM	In a first-of-its-kind fixed dose study, once weekly insulin efsitora alfa leads to A1C reduction similar to daily insulin (PR Newswire)
06:05AM	Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year (Motley Fool)
04:12AM	Lilly and EVA Pharma to expand baricitinib access in Africa (Pharmaceutical Technology)
Sep-04-24 12:34PM	How Lilly, Novo Could Beat Tesla To The Trillion-Dollar Club; Plus, Nvidia's Battle With Microsoft, Apple (Investor's Business Daily)
12:00PM	Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy? (Zacks)
11:40AM	Alzheimers Trial Failure Sends Athira Stock Down 75% (Barrons.com)
07:35AM	Health Care Roundup: Market Talk (The Wall Street Journal)
06:00AM	Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries (PR Newswire)
Sep-03-24 11:32PM	Is Eli Lilly and Company (LLY) the Best Cancer Stock to Buy Now? (Insider Monkey)
10:08PM	Is Eli Lilly and Company (LLY) Splitting Soon? (Insider Monkey)
04:14PM	Eli Lilly partner BioAge files for US IPO (Reuters)
09:45AM	The Best Biotech Stock to Invest $1,000 in Right Now (Motley Fool)
09:17AM	Moderna, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring (Barrons.com)
07:09AM	Novo Nordisk Says Ozempic Shortage Is Worsening. Why Its Good News For Eli Lilly. (Barrons.com)
12:00AM	Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring (Barrons.com)
Sep-02-24 02:47PM	10 Best ESG Stocks To Buy Now (Insider Monkey)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LILLY ENDOWMENT INC	10% Owner	Sep 03 '24	Sale	966.69	24,084	23,281,840	96,891,978	Sep 04 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 27 '24	Sale	968.46	24,552	23,777,668	96,916,062	Aug 28 04:05 PM
Zakrowski Donald A	Officer	Aug 26 '24	Proposed Sale	950.00	750	712,500		Aug 26 04:47 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 26 '24	Sale	950.00	750	712,500	6,380	Aug 26 04:21 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Sale	966.33	3,196	3,088,382	96,940,614	Aug 23 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Proposed Sale	951.97	215,000	204,673,550		Aug 22 12:54 PM
LILLY ENDOWMENT INC	10% Owner	Jul 10 '24	Sale	939.82	210,000	197,361,398	96,943,810	Jul 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 08 '24	Sale	918.64	93,593	85,977,954	97,153,810	Jul 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 05 '24	Sale	915.18	52,369	47,927,194	97,247,403	Jul 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 03 '24	Sale	915.31	8,848	8,098,655	97,299,772	Jul 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 01 '24	Sale	915.26	58,749	53,770,776	97,308,620	Jul 02 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 28 '24	Sale	915.02	1,441	1,318,545	97,367,369	Jul 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 25 '24	Sale	903.82	188,100	170,009,262	97,368,810	Jun 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 24 '24	Sale	902.38	17,229	15,547,068	97,556,910	Jun 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 20 '24	Sale	902.67	9,671	8,729,733	97,574,139	Jun 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 17 '24	Sale	885.91	194,978	172,733,708	97,583,810	Jun 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 14 '24	Sale	882.47	15,022	13,256,490	97,778,788	Jun 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 10 '24	Sale	860.78	75,510	64,997,274	97,793,810	Jun 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 07 '24	Sale	852.29	139,490	118,886,587	97,869,320	Jun 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 06 '24	Sale	837.82	179,617	150,485,878	98,008,810	Jun 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 05 '24	Sale	836.32	20,383	17,046,673	98,188,427	Jun 06 04:00 PM
Rau Diogo	EVP & CIDO	Jun 01 '24	Option Exercise	0.00	6,300	0	14,146	Jun 04 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Jun 03 '24	Sale	829.77	192,794	159,974,050	98,208,810	Jun 04 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Jun 03 '24	Sale	819.47	750	614,602	7,130	Jun 03 04:15 PM
Norton Johna	EVP, Global Quality	Jun 03 '24	Sale	819.38	7,056	5,781,545	25,428	Jun 03 04:14 PM
LILLY ENDOWMENT INC	10% Owner	May 31 '24	Sale	822.11	22,206	18,255,871	98,401,604	Jun 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 29 '24	Sale	811.04	130,385	105,747,975	98,423,810	May 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 28 '24	Sale	809.00	2,052	1,660,068	98,554,195	May 29 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 24 '24	Sale	809.21	92,563	74,902,998	98,556,247	May 28 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 23 '24	Sale	809.99	50,767	41,120,963	98,648,810	May 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 22 '24	Sale	804.18	12,974	10,433,483	98,699,577	May 23 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 21 '24	Sale	805.45	186,259	150,021,694	98,712,551	May 22 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 11 '24	Sale	753.60	750	565,200	7,880	Mar 11 04:27 PM
LILLY ENDOWMENT INC	10% Owner	Feb 16 '24	Sale	780.99	169,684	132,521,930	98,898,810	Feb 20 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 15 '24	Sale	760.46	50,316	38,263,417	99,068,494	Feb 16 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 09 '24	Sale	740.60	206,257	152,753,428	99,118,810	Feb 12 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 08 '24	Sale	740.06	8,743	6,470,336	99,325,067	Feb 09 04:05 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '24	Option Exercise	0.00	4,442	0	26,631	Feb 02 04:32 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '24	Option Exercise	0.00	3,702	0	16,676	Feb 02 04:29 PM
Ricks David A	President, Chair, and CEO	Feb 01 '24	Option Exercise	0.00	29,611	0	455,054	Feb 02 04:28 PM
Jonsson Patrik	EVP&Pres, LLY Dia&Obe, LLY USA	Feb 01 '24	Option Exercise	0.00	4,124	0	41,065	Feb 02 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '24	Option Exercise	0.00	9,941	0	115,262	Feb 02 04:25 PM
Norton Johna	EVP, Global Quality	Feb 01 '24	Option Exercise	0.00	1,268	0	31,382	Feb 02 04:24 PM
Van Naarden Jacob	EVP & Pres., Loxo@Lilly	Feb 01 '24	Option Exercise	0.00	3,618	0	15,463	Feb 02 04:22 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '24	Option Exercise	0.00	4,124	0	62,050	Feb 02 04:20 PM
LILLY ENDOWMENT INC	10% Owner	Jan 31 '24	Sale	648.07	78,573	50,920,924	99,333,810	Feb 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 30 '24	Sale	645.22	76,215	49,175,200	99,412,383	Jan 31 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 29 '24	Sale	645.07	54,032	34,854,422	99,488,598	Jan 30 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 16 '24	Sale	645.60	1,180	761,806	99,542,630	Jan 17 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 11 '24	Sale	634.13	12,344	7,827,686	99,543,810	Jan 12 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 10 '24	Sale	630.59	163,730	103,246,373	99,556,154	Jan 11 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 09 '24	Sale	631.81	34,538	21,821,413	99,719,884	Jan 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 04 '24	Sale	630.28	14,388	9,068,445	99,754,422	Jan 05 02:15 PM
Zakrowski Donald A	SVP, Finance, & CAO	Dec 01 '23	Option Exercise	0.00	4,810	0	9,518	Dec 04 04:17 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 06 '23	Sale	571.10	670	382,637	4,708	Nov 06 04:25 PM
LILLY ENDOWMENT INC	10% Owner	Oct 11 '23	Sale	605.44	215,000	130,169,879	99,768,810	Oct 12 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience